Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs has established a broad range of platforms for developing novel antibodies or equivalents. These cutting-edge technologies enable our scientists to meet your demands from different aspects and tailor the most appropriate solution that contributes to the success of your projects.
HighlightsWith deep understanding in antibody-related realms and extensive project experience, Creative Biolabs offers a variety of references to help you learn more about our capacities and achievements, including infographic, flyer, case study, peer-reviewed publications, and all kinds of knowledge that can assist your projects. You are also welcome to contact us directly for more specific solutions.
HighlightsGet a real taste of Creative Biolabs, one of the most professional custom service providers in the world. We are committed to providing highly customized comprehensive solutions with the best quality to advance your projects.
Highlights
Loading...All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
TNF receptor superfamily member 12A (TNFRSF12A, also known as Fn14) is a single‑pass transmembrane signaling receptor encoded by the TNFRSF12A gene, expressed on plasma membranes of multiple stromal and immune cell populations. Its extracellular cysteine‑rich domain mediates specific binding to its primary ligand TNFSF12 (TWEAK). Upon TWEAK engagement, TNFRSF12A undergoes receptor clustering and recruits intracellular TRAF‑family adaptor proteins, which trigger downstream signalling cascades that may include NF‑κB and MAPK pathways. The output intensity and duration of cellular responses are governed by receptor expression level and cellular context. TNFRSF12A functions as an active signal‑transducing receptor and does not act as a ligand‑sequestering decoy receptor.
Sequence variants within the TNFRSF12A gene may alter TWEAK binding capacity, receptor‑clustering behaviour or TRAF adaptor recruitment, consequently changing downstream signalling outputs. TNFRSF12A couples extracellular TNFSF12/TWEAK ligand recognition to intracellular TRAF‑dependent signalling via its membrane‑anchored architecture and short cytoplasmic TRAF‑binding segment, setting it apart from soluble ligand‑binding proteins. Altered TNFRSF12A expression levels can modify TWEAK‑driven NF‑κB and MAPK signalling in cellular model systems, making it a valuable research target for investigating TNF‑superfamily‑mediated tissue responses.
Fig. 1 Domain‑architecture comparison of representative TNF‑receptor‑superfamily members including TNFRSF12A (Fn14). TNFRSF12A corresponds to single‑pass transmembrane receptor, which contains one extracellular cysteine‑rich domain and a short cytoplasmic segment harbouring TRAF‑family adaptor‑binding motif.1
Creative Biolabs offers purified TNFRSF12A membrane samples produced under unified preparation workflows, including full‑length TNFRSF12A constructs and isolated extracellular domain variants. Truncated extracellular fragments cannot support complete receptor signalling behaviour, while full‑length constructs fit research focused on TWEAK binding and receptor activation. All batches receive uniform quality screening. Functional assessments may only be performed on full‑length protein under simulated membrane microenvironment setups. Consistent structural features are preserved across batches to support comparative laboratory analysis between experimental groups. Full‑length TNFRSF12A samples maintain intact extracellular ligand‑binding and cytoplasmic adaptor‑recruitment features after standardized purification, supporting comparative analysis of TWEAK‑receptor interactions and signalling‑related behaviour.
Not finding the Membrane protein product you need? Contact us to start your one-stop custom service!
Creative Biolabs provides adjustable TNFRSF12A expression cell models with varied expression levels, applicable to TNF receptor structural observation and TWEAK‑receptor signalling research. Sample evaluation includes sustained target expression detection, ligand interaction analysis, and downstream signalling readouts, supporting comparative analysis under different expression statuses. These cell systems can be matched with diverse laboratory analysis schemes to observe changes in TWEAK responsiveness under different target expression abundances.
Not finding the stable cell line product you need? Contact us to start your one-stop custom service!
Antibody reagents targeting TNFRSF12A are generated via mature protein preparation workflows, compatible with multiple routine laboratory detection methods for cellular localization profiling and molecular complex identification, to support systematic analysis of TNFRSF12A distribution and TWEAK ligand binding complexes across diverse laboratory research setups. The antibody series can cooperate with other common laboratory detection reagents to complete multi dimensional observation of target distribution inside tissue samples.
Not finding the recombinant antibody product you need? Contact us to start your one-stop custom service!
Beyond catalog products, Creative Biolabs offers specialized custom services for TNFRSF12A research:
TNFRSF12A functions as a TNFSF12/TWEAK receptor that can recruit TRAF‑family adaptors after ligand‑induced clustering and mediate downstream signalling.
TNFRSF12A expression status may affect TWEAK‑induced signalling intensity and downstream cellular responses, serving as a major regulatory mediator of tissue cytokine‑related biological processes.
No, all TNFRSF12A related products and services are strictly for research use only, not intended for clinical related operations. All material designs and functional tests are only optimized for basic laboratory research scenarios, without matching clinical application standards.
Offerings include full‑length TNFRSF12A membrane protein, target‑specific recombinant antibodies and adjustable expression cell research models, supporting TWEAK‑Fn14 receptor signalling research.
Laboratory analysis schemes may include TWEAK‑binding and receptor‑activation assays to assess molecular interaction and signalling capacity under simulated membrane environments.
